Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ORMP stock: Oramed Pharmaceuticals, Inc.

Current Rating
Sell

Previous Rating:

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$10.71
Market Cap
115.2M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
5.63
P/S
50.93
Dividend %
-
P/CF
-
P/FCF
36.0
Op. Cash Flow
3K
FCF
0.2
Op. Margin
-522.50%
Net Margin
-572.50%
ROE
-55.00%
ROI
-43.30%
ROA
-29.60%
EPS Growth
-38.20%
Current Ratio
8.7
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Dyadic International, Inc. (DYAI) $1.46 - - 42.8M Strong Buy
Palatin Technologies, Inc. (PTN) $0.66 - - 65.7M Strong Buy
IRIDEX Corporation (IRIX) $9.43 - - 103M Strong Buy
Biomerica, Inc. (BMRA) $2.82 - - 22.6M Strong Buy
Envision Healthcare Corp (EVHC) $44.69 - - 6.33B Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More